全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

CT引导下的碘125粒子植入治疗不可切除胰腺癌的有效性和安全性综述
The Efficacy and Safety of Iodine-125 Particle Implantation for Unresectable Pancreatic Cancer under CT Guidance: A Comprehensive Systematic Review

DOI: 10.12677/acrem.2024.124017, PP. 111-116

Keywords: 碘125粒子,胰腺癌,安全性,有效性,综述
Iodine-125 Particles
, Pancreatic Cancer, Security, Validity, Review

Full-Text   Cite this paper   Add to My Lib

Abstract:

胰腺癌是高度恶性的消化系统肿瘤,早期难以诊断且预后不良。全球胰腺癌五年生存率一直低于5%。尽管有多种治疗方法,但碘125粒子植入因其独特优势而备受关注,故对碘125粒子植入在不可切除胰腺癌中的疗效和安全性展开综述。CT引导下经皮粒子植入具有手术时间短、出血少、恢复快、并发症少且医疗费用低的优势。研究表明,该技术能有效控制肿瘤生长,缓解疼痛,延长寿命。碘125粒子植入可单独或与其他疗法结合使用,但需统一剂量和程序以指导临床实践。
Pancreatic cancer is a highly malignant digestive system tumor that is difficult to diagnose in its early stages and has a poor prognosis. The five-year survival rate for pancreatic cancer worldwide is less than 5%. Despite various treatment options, iodine-125 (I-125) seed implantation has garnered considerable attention due to its unique advantages, so a systematic review of the efficacy and safety of I-125 seed implantation in unresectable pancreatic cancer is conducted. Percutaneous seed implantation under CT or ultrasound guidance has the advantages of short operation time, minimal bleeding, fast recovery, fewer complications, and lower medical costs. Studies have shown that this technology can effectively control tumor growth, alleviate pain, and prolong survival. I-125 seed implantation can be used alone or in combination with other therapies, but a uniform dose and protocol should be followed to guide clinical practice.

References

[1]  Siegel, R.L., Fedewa, S.A., Miller, K.D., Goding‐Sauer, A., Pinheiro, P.S., Martinez‐Tyson, D., et al. (2015) Cancer Statistics for Hispanics/Latinos, 2015. CA: A Cancer Journal for Clinicians, 65, 457-480.
https://doi.org/10.3322/caac.21314
[2]  Ilic, M. and Ilic, I. (2016) Epidemiology of Pancreatic Cancer. World Journal of Gastroenterology, 22, 9694-9705.
https://doi.org/10.3748/wjg.v22.i44.9694
[3]  Kamisawa, T., Wood, L.D., Itoi, T. and Takaori, K. (2016) Pancreatic Cancer. The Lancet, 388, 73-85.
https://doi.org/10.1016/s0140-6736(16)00141-0
[4]  Li, Q., Tian, Y., Yang, D., Liang, Y., Cheng, X. and Gai, B. (2019) Permanent Iodine-125 Seed Implantation for the Treatment of Nonresectable Retroperitoneal Malignant Tumors. Technology in Cancer Research & Treatment, 18, 1-8.
https://doi.org/10.1177/1533033819825845
[5]  Zhao, G.S., Liu, S., Liu, H., Lv, W.C., Yang, L., Li, C., et al. (2022) Evaluation of the Efficacy of CT-Guided 3D Template-Assisted 125I Seed Implantation in the Treatment of Unresectable STS: A Multicenter Retrospective Study. Scientific Reports, 12, Article No. 3731.
https://doi.org/10.1038/s41598-022-07729-9
[6]  Liu, K., Ji, B., Zhang, W., Liu, S., Wang, Y. and Liu, Y. (2014) Comparison of Iodine-125 Seed Implantation and Pancreaticoduodenectomy in the Treatment of Pancreatic Cancer. International Journal of Medical Sciences, 11, 893-896.
https://doi.org/10.7150/ijms.8948
[7]  Holm, H.H., Strøyer, I., Hansen, H. and Stadil, F. (1981) Ultrasonically Guided Percutaneous Interstitial Implantation of Iodine 125 Seeds in Cancer Therapy. The British Journal of Radiology, 54, 665-670.
https://doi.org/10.1259/0007-1285-54-644-665
[8]  Yu, Y., Yu, Q., Guo, J., Jiang, H., Di, X. and Zhu, Y. (2014) Effectiveness and Security of CT-Guided Percutaneous Implantation of 125I Seeds in Pancreatic Carcinoma. The British Journal of Radiology, 87, Article ID: 20130642.
https://doi.org/10.1259/bjr.20130642
[9]  Hu, Y., Qi, E., Liu, F., Lu, Y., Tan, S., Sun, Y., et al. (2018) The Application of a Three-Dimensional Visualized Seed Planning and Navigation System in 125I Seed Implantation for Pancreatic Cancer. OncoTargets and Therapy, 11, 619-627.
https://doi.org/10.2147/ott.s141245
[10]  Wang, J., Jiang, Y., Li, J., Tian, S., Ran, W. and Xiu, D. (2009) Intraoperative Ultrasound-Guided Iodine-125 Seed Implantation for Unresectable Pancreatic Carcinoma. Journal of Experimental & Clinical Cancer Research, 28, Article No. 88.
https://doi.org/10.1186/1756-9966-28-88
[11]  Wang, Z. (2015) Biological Effects of Low-Dose-Rate Irradiation of Pancreatic Carcinoma Cells in Vitro Using 125I Seeds. World Journal of Gastroenterology, 21, Article No. 2336.
https://doi.org/10.3748/wjg.v21.i8.2336
[12]  Lu, Z., Dong, T., Si, P., Shen, W., Bi, Y., Min, M., et al. (2016) Continuous Low-Dose-Rate Irradiation of Iodine-125 Seeds Inhibiting Perineural Invasion in Pancreatic Cancer. Chinese Medical Journal, 129, 2460-2468.
https://doi.org/10.4103/0366-6999.191777
[13]  Handley, W.S. (1934) Pancreatic Cancer and Its Treatment by Implanted Radium. Annals of Surgery, 100, 215-223.
https://doi.org/10.1097/00000658-193407000-00021
[14]  Fortner, J.G., D’Angio, G.J., Hilaris, B.S., Arthur, K., Murphy, J.M. and Fischer, H.J. (1970) Iodine 125 Implantation for Unresectable Cancer of the Pancreas. Postgraduate Medicine, 47, 226-230.
https://doi.org/10.1080/00325481.1970.11697415
[15]  Hilaris, B.R.K. (1975) Cancer of the Pancreas. In: Hilaris, B.S., Ed., Handbook of Interstitial Brachytherapy, Publishing Sciences Group (PSG), Acton, 251-262.
[16]  Wang, K., Jin, Z., Du, Y., Zhan, X., Zou, D., Liu, Y., et al. (2012) EUS-Guided Celiac Ganglion Irradiation with Iodine-125 Seeds for Pain Control in Pancreatic Carcinoma: A Prospective Pilot Study. Gastrointestinal Endoscopy, 76, 945-952.
https://doi.org/10.1016/j.gie.2012.05.032
[17]  Li, Y., Liu, B., Zhou, T., Geng, J., Zhang, F. and Wang, J. (2015) Percutaneous Computed Tomography-Guided Iodine-125 Seeds Implantation for Unresectable Pancreatic Cancer. Indian Journal of Cancer, 52, Article No. 69.
https://doi.org/10.4103/0019-509x.172517
[18]  Gai, B. and Zhang, F. (2018) Chinese Expert Consensus on Radioactive 125I Seeds Interstitial Implantation Brachytherapy for Pancreatic Cancer. Journal of Cancer Research and Therapeutics, 14, Article No. 1455.
https://doi.org/10.4103/jcrt.jcrt_96_18
[19]  Wang, J., Chai, S., Zheng, G., Jiang, Y., Ji, Z., Guo, F., et al. (2018) Expert Consensus Statement on Computed Tomography-Guided 125I Radioactive Seeds Permanent Interstitial Brachytherapy. Journal of Cancer Research and Therapeutics, 14, 12-17.
https://doi.org/10.4103/jcrt.jcrt_888_17
[20]  Lv, W., Lu, D., Xiao, J., Mukhiya, G., Tan, Z., Cheng, D., et al. (2017) The Side Effects and Complications of Percutaneous Iodine-125 Seeds Implantation under Ct-Guide for Patients with Advanced Pancreatic Cancer. Medicine, 96, e9535.
https://doi.org/10.1097/md.0000000000009535
[21]  Wang, H., Wang, J., Jiang, Y., Li, J., Tian, S., Ran, W., et al. (2013) The Investigation of 125I Seed Implantation as a Salvage Modality for Unresectable Pancreatic Carcinoma. Journal of Experimental & Clinical Cancer Research, 32, Article No. 106.
https://doi.org/10.1186/1756-9966-32-106
[22]  Ye, X. and Saito, S. (2017) Expert Consensus Workshop Report: Guideline for Three-Dimensional-Printing Template-Assisted Computed Tomography-Guided 125I Seeds Interstitial Implantation Brachytherapy. Journal of Cancer Research and Therapeutics, 13, Article No. 605.
https://doi.org/10.4103/jcrt.jcrt_540_17
[23]  Ye, X. and Hertzanu, Y. (2018) A Valuable Guideline of Radioactive 125I Seeds Interstitial Implantation Brachytherapy for Pancreatic Cancer. Journal of Cancer Research and Therapeutics, 14, Article No. 1453.
https://doi.org/10.4103/jcrt.jcrt_726_18
[24]  Strosberg, J., Hoffe, S., Gardner, N., Choi, J. and Kvols, L. (2007) Effective Treatment of Locally Advanced Endocrine Tumors of the Pancreas with Chemoradiotherapy. Neuroendocrinology, 85, 216-220.
https://doi.org/10.1159/000102969

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133